Review
Oct 2026
Neuroimaging in the era of biologically defined Alzheimer's disease and disease-modifying therapy.
Neuroimaging is now a cornerstone of Alzheimer's disease care and a crucial discriminator tool for characterising brain injury across the lifespan and with emerging fluid biomarkers, neuroimaging supports accurate diagnosis, prognosis, and treatment monitoring.
Tammie L. S. Benzinger, P. Cogswell, A. Arani et al.
· Lancet Neurology · 2 citations